EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Penicillin binding protein 4: an emerging Staphylococcus aureus therapeutic target

Vijay Singh Gondil, Monica A Stefaniak, Christian Melander, Paul M Dunman

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1940058 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Vijay Singh Gondil und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States. Hauptthemen laut MEDLINE: Penicillin-Binding Proteins, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus penicillin-binding protein 4 (PBP4) is a non-essential, low-molecular-weight transpeptidase that contributes to peptidoglycan maintenance under conventional laboratory growth conditions. Several recent studies have suggested that the protein’s cellular functions have far-reaching consequences, directly affecting S. aureus success as a human pathogen. Herein, we review recent work implicating PBP4 as a modulator of a noncanonical PBP2A-independent methicillin-resistant S. aureus (MRSA) phenotype that extends to the most recently developed fifth-generation cephalosporins. Furthermore, we review emerging studies indicating that PBP4 is a previously unappreciated virulence factor that governs an essential step in osteomyelitis pathogenesis, namely the invasion of osteocyte lacuna-canalicular networks (OLCNs). Given the protein’s involvement in these two disease-related processes, we discuss PBP4’s potential as a non-traditional antimicrobial therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Penicillin-Binding ProteinsStaphylococcal InfectionsStaphylococcus aureusHumansAnti-Bacterial AgentsOsteomyelitisVirulence FactorsMethicillin-Resistant Staphylococcus aureusPeptidoglycanbeta Lactam Antibiotics

Stichwörter der Autor:innen

Staphylococcus aureusantibiotic resistanceantimicrobialosteomyelitispenicillin binding protein 4 (PBP4)peptidoglycan synthesisβ-lactams

Substanzen

Penicillin-Binding ProteinsAnti-Bacterial AgentsVirulence FactorsPeptidoglycanbeta Lactam Antibiotics

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States.
  • Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, United States.

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Gondil, V. S., Stefaniak, M. A., Melander, C., & Dunman, P. M. (2026). Penicillin binding protein 4: an emerging Staphylococcus aureus therapeutic target. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1940058

Vancouver

Gondil VS, Stefaniak MA, Melander C, Dunman PM. Penicillin binding protein 4: an emerging Staphylococcus aureus therapeutic target. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1940058

BibTeX
@article{Gondil2026,
  author = {Gondil, Vijay Singh and Stefaniak, Monica A and Melander, Christian and Dunman, Paul M},
  title = {Penicillin binding protein 4: an emerging Staphylococcus aureus therapeutic target},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1940058}
}
Kostenlos starten →